In a recent study, fisetin showed neuroprotection in rotenone-induced toxicity in the cellular model of Parkinson's disease by inhibiting the expression of Bax and caspase-3, and upregulating the expression of Bcl-2 (94). The gene discussed is BCL2; the disease is Parkinson disease.